Thrombopoietin level in young patients is related to megakaryocyte frequency and platelet count

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 1, 1998, Pages 36-43

  Kuefer, Martin U ^a   Wang, Winfred C ^a,b   Head, David R ^a   Wilimas, Judith A ^a,b   Furman, Wayne L ^d   Liu, Qing ^a   Hornkohl, Alex C ^c   Best, Dawn M ^c   Jackson, Carl W ^d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c AMGEN INC   (United States)

^d NONE

Author keywords

Children; Megakaryocytes; Platelets; Thrombopoietin

Indexed keywords

THROMBOPOIETIN;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; BONE MARROW CELL; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; HUMAN; LIGAND BINDING; MALE; MEGAKARYOCYTE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MALE; MEGAKARYOCYTES; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 0031886325     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199801000-00006     Document Type: Article

References (35)

1. Skoda RC, Seldin DC, Chiang MK, et al. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J 1993;12:2645-53.
2. Vigon I, Florindo C, Fichelson S, et al. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene 1993;8:2607-15.
3. Vigon I, Mornon JP, Cocault L, et al. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992;89:5640-4.
4. Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-8.
5. Hartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-24.
6. de Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakary-ocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-8.
7. Fanucchi M, Glaspy J, Crawford J, et al. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. N Engl J Med 1997;336:404-9.
8. Odell TT Jr, Jackson CW, Reiter RS. Depression of the megakaryocyte-platelet system in rats by transfusion of platelets. Acta Haematol 1967;38:34-42.
9. Harker LA. Kinetics of thrombopoiesis. J Clin Invest 1968;47:458-65.
10. Penington DG, Olsen TE. Megakaryocytes in states of altered platelet production: cell numbers, size and DNA content. Br J Haematol 1970;18:447-63.
11. Jackson CW, Brown LK, Somerville BC, et al. Two-color flow cytometric measurement of DNA distributions of rat megakaryocytes in unfixed, unfractioned marrow cell suspensions. Blood 1984;63: 768-78.
12. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995;85:2720-30.
13. De Gabriele G, Penington DG. Regulation of platelet production: "thrombopoietin." Br J Haematol 1967;13:210-15.
14. Miura M, Jackson CW, Steward SA. Increase in circulating megakaryocyte growth-promoting activity (Meg-GPA) following sublethal irradiation is not related to decreased platelets. Exp Hematol 1988;16:139-44.
15. Emmons RVB, Reid DM, Cohen RL, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996;87:4068-71.
16. Tomer A. Harker LA. Burstein SA. Flow cytometric analysis of normal human megakaryocytes. Blood 1988;71:1244-52.
17. Marsh JC, Gibson FM, Prue RL, et al. Serum thrombopoietin levels in patients with aplastic anaemia. Br J Haematol 1996;95:605-10.
18. Nichol JL, Hokom MM, Hornkohl A, et al. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 1995;95:2973-78.
19. Kaushansky K, Lok S, Holly RD, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994;369:568-71.
20. Gurney AL, Carver-Moore K, de Sauvage FJ, et al. Thrombocytopenia in c Mpl deficient mice. Science 1994;265:1445-47.
21. Kaushansky K, Broudy VC, Lin N, et al. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995;92:3234-38.
22. Wendung F, Maraskovsky E, Debili N, et al. cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994;369:571-74.
23. Farese AM, Hunt P, Boone T, et al. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995;86:54-59.
24. Miura M, Jackson CW, Lyles SA. Increase in circulating megakaryocyte growth promoting activity in the plasma of rats following whole body irradiation. Blood 1984;63:1060-66.
25. Harker LA, Hunt P, Malzec UM, et al. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood 1996;87:1833-44.
26. Aul C, Gattermann N, Schneider W. Epidemiological and etiological aspects of myelodysplastic syndromes. Leak Lymphoma 1995;16:247-62.
27. Mittelman MM, Lessin LS. Oncogenes and growth factor genes in myelodysplasia. Hematol Pathol 1991;5:37-41.
28. List AF, Jacobs A. Biology and pathogenesis of the myelodysplastic syndromes. Semin Oncol 1992;19:14-24.
29. Layton DM. The molecular biology of myelodysplastic syndromes (preleukemia). In: Mufti GJ, Galton DAG (eds). The Myelodysplastic Syndromes. Edinburgh: Churchill Livingstone, 1992;151-95.
30. Fielder PJ, Gurney AL, Stefanich E, et al. Regulation of thrombopoietin levels by c mpl-mediated binding to platelets. Blood 1996;87:2154-61.
31. Kearns CM, Wang WC, Stute N, et al. Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropenia. J Pediatr 1993;123:471-79.
32. Nichol JL. Serum levels of thrombopoietin in health and disease. In: Kuter DJ, Hunt P, Sheridan W, et al. (eds). Thrombopoiesis and Thrombopoietins. Totowa, NJ: Humana Press, 1997;359-375.
33. Ichikawa N, Ishida F, Shimodaira S, et al. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura. Thromb Haemost 1996;76:156-60.
34. Usuki K, Tahara T, Iki S, et al. Serum thrombopoietin level in various hematological diseases. Stem Cells 1996;14:558-65.
35. Halperin DS, Doyle JJ. Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child 1988;142:508-11.